Browsing by Author Flemming, Claudia L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2014ABCA transporter gene expression and poor outcome in epithelial ovarian cancerdeFazio, Anna; Emmanuel, Catherine; Gao, Bo; Harnett, Paul; Beesley, Johnathan; Chen, Xiaoqing; et al, Various; Flemming, Claudia L.; George, Joshy; Hedditch, Ellen; Johnatty, Sharon E.; Li, Yi; Russell, Amanda; Study Group, Australian Ovarian Cancer; William, Rebekka T; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Medicine (Westmead)ABCA transporter gene expression and poor outcome in epithelial ovarian cancer, Journal of the National Cancer Institute, vol.106, 7, 2014,pp 1-11
2005Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitroAllen, John; Tanabe, K; Tobin, Peter; Cohn, Susan L.; Flemming, Claudia L.; Haber, Michelle; London, Wendy B.; Marshall, Glenn M.; Norris, Murray D.; Scheffer, George L.; Smith, Janice; Wielinga, Peter; Central Clinical School: Centenary Institute; Clinical Schools; School of Medical Sciences: PharmacologyExpression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro, Molecular cancer therapeutics, vol.4,(4),2005,pp 547-553
2003Microtubule Alterations and Mutations Induced by Desoxyepothilone B - Implications for Drug-Target InteractionsIvery, Michael; Cobon, Gary S.; Flemming, Claudia L.; Haber, Michelle; Kavallaris, Maria; Liu, Marjorie; Norris, Murray D.; Verrills, Nicole M.; PharmacyMicrotubule Alterations and Mutations Induced by Desoxyepothilone B - Implications for Drug-Target Interactions, Chemistry & Biology, vol.10,(7),2003,pp 597-607
2015MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaAshton, Lesley; Brors, Benedikt; et al, Various; Fischer, Matthias; Flemming, Claudia L.; Gherardi, Samuele; Juraeva, Dilafruz; Lau, Diana; Norris, Murray D.; Oberthuer, Andre; Perini, Giovanni; Xue, Chengyuan; Research Grants and ContractsMYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma, Oncotarget, vol.6, 17, 2015,pp 15510-15523
2017Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivoByrne, Jennifer; Allan, Sophie; Cheung, Leanna; Eden, Georgina L.; Flemming, Claudia L.; Fletcher, J; Gamble, Laura; Gifford, Andrew J; Haber, M; Hanssen, Kimberley M.; Henderson, Michelle; Murray, J; Norris, Murray; Ruhle, Michelle; Saletta, Federica; Schuetz, John D.; Tan, Alvin; Tivnan, Amanda; Truong, Alan M.; Valli, Emanuele; Yu, Denise; Childrens Hospital Westmead: Paediatrics & Child HealthSuppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo, European Journal of Cancer, vol.83, N/A, 2017,pp 132-141